Alarming study: Only one in ten people with type 2 diabetes receives optimal care!

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

A new study on diabetes care in Austria shows alarming results for the treatment of type 2 diabetics.

Eine neue Studie zur Diabetesversorgung in Österreich zeigt alarmierende Ergebnisse zur Behandlung von Typ-2-Diabetikern.
A new study on diabetes care in Austria shows alarming results for the treatment of type 2 diabetics.

Alarming study: Only one in ten people with type 2 diabetes receives optimal care!

A comprehensive study into the medical care conditions of type 2 diabetics in Austria has revealed alarming results. Only about 50 percent of patients reached the recommended levels for blood sugar, LDL cholesterol and blood pressure. Besonders besorgniserregend: Nur 13 Prozent der Teilnehmer fanden sich in allen drei Gesundheitsbereichen im optimalen „grünen Bereich“, wie die crown reported. The study, which involved 635 diabetics, shows that many people are not receiving adequate treatment. The diabetes rate in Austria is now almost 800,000 people affected, with cardiovascular diseases being widespread among these patients.

The challenges in diabetes care are not only noticeable in Austria. A new long-term study published in the respected journal The Lancet shows that early diagnosis and immediate intensive treatment of type 2 diabetes can significantly reduce serious health complications, including mortality and heart disease. These findings support the German Diabetes Society (DDG) in its call for better screening in order to identify and treat undetected cases of diabetes, of which there are around 2 million in Germany, at an early stage. Professor Dr. Julia Szendrödi explains: “The longer diabetes remains undetected, the greater the risk of serious complications,” and points out the need for comprehensive screening measures.

Long-term benefits of early therapy

The UKPDS study, carried out back in 1998, showed that immediate intensive treatment of diabetes 2 brings significant health benefits. After 10 years of follow-up, patients who were treated early had a 12 percent reduced risk of diabetes complications and a 16 percent lower risk of heart attacks. The results of this study underline the long-term benefits of early therapy, which can also increase the life expectancy of those affected, as highlighted in the DDG study. These findings are particularly important given the everyday challenges in diabetes care in order to continuously improve the quality of care and take gender medicine into account, as women have a higher risk of cardiovascular diseases.